Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Csl Ltd (CMXHF)

Csl Ltd (CMXHF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Csl Ltd

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

CSL Ltd is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company produces life-saving and life-enhancing medicines that enable people around the world to live a normal healthy life. It is a specialty biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. The Company's areas of expertise are Plasma Products: Human plasma is used to produce a wide range of life-saving medicines. The key businesses involved with plasma products include: CSL Behring and CSL Behring (Australia). Vaccines & Pharmaceuticals: manufactures and provides influenza vaccine. The Company's segments are CSL Behring: manufactures, markets and develops plasma therapies (plasma products and recombination's); biosCSL: manufactures and distributes non-plasma biotherapeutic products and CSL Intellectual Property: revenue & associated expenses from the licensing if Intellectual Property generated by the group to unrelated third parties and Research & Development expenses. The Company operates in four geographical areas, namely Australia, USA, Switzerland and Germany.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 0.75

Growth:

1-Year Return -30.71%
3-Year Return -41.83%
5-Year Return -45.34%

Per-Share Information:

Next Earnings Date N/A
Next Ex-Dividends Date 03/16/15
Dividend Payable Date 04/10/15
Dividend Payout Ratio 0.00%

CMXHF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 29.66
Price/Book 12.45
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar